Hjem › Glioblastom › District of Columbia › Washington
Kliniske studier for Glioblastom i Washington, DC
15 studier for Glioblastom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservasjonsstudie
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
RekruttererFase 1
- Children's National Hospital, Washington D.C.
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
RekruttererFase 1
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Sibley Memorial Hospital, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
RekruttererFase 1
- National Institutes of Health, Bethesda · 7 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi unna
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi unna
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
RekruttererFase 1/2
- Sibley Memorial Hospital, Washington D.C.
Glioblastom-studier i andre byer
- New York City, NY30 studier
- Boston, MA28 studier
- Houston, TX26 studier
- Los Angeles, CA24 studier
- Durham, NC20 studier
- San Francisco, CA17 studier
- Chicago, IL15 studier
- Columbus, OH14 studier
- Miami, FL14 studier
- Rochester, MN13 studier
- Jacksonville, FL13 studier
- Aurora, CO12 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.